Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Double Blind Placebo Controlled Trial of Perhexiline in Heart Failure With Preserved Ejection Fraction Syndrome (HFpEF)

NCT00839228 is registered in ClinicalTrials.gov with University of Aberdeen as lead sponsor.

NCT NCT00839228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00839228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Double Blind Placebo Controlled Trial of Perhexiline in Heart Failure With Preserved Ejection Fraction Syndrome (HFpEF)
Lead sponsor
University of Aberdeen
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2009
Completion date
February 28, 2014
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diastolic heart failure